Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Plast Reconstr Surg Glob Open ; 10(1): e3925, 2022 Jan.
Article de Anglais | MEDLINE | ID: mdl-35083100

RÉSUMÉ

Nonmelanoma skin cancers constitute more than 15% of all types of cancer. To obtain the best cosmetic outcome, local flaps represent the ideal surgical choice. METHODS: We conducted a retrospective review of patients treated from 2016 to 2019. The day-surgery group included 73 patients, and the outpatient group included 70 patients. We analyzed medical records regarding age of diagnosis, waiting time, site of lesion, reconstructive technique, histologic diagnosis, radicality of excision, and complications. We administered a survey based on quality items and carried out an economic evaluation. RESULTS: Outpatient removals were radical 92.6% of the time against the 78% of those performed in the operating room (P = 0.14). We observed two cases of wound dehiscence and two cases of hematoma in the day-surgery group. Economic analysis showed reduced costs in the outpatient setting. CONCLUSION: Skin excision and local flap reconstruction are safe procedures in an outpatient setting under a clinical, economical, and patient perception point of view.

4.
Biomed Res Int ; 2021: 6650846, 2021.
Article de Anglais | MEDLINE | ID: mdl-33791369

RÉSUMÉ

BACKGROUND: Surgical site infection represents the most severe complication in prosthetic breast reconstruction. Risk profiling represents a useful tool for both clinicians and patients. MATERIALS AND METHODS: In our hospital, 534 breast reconstructions with tissue expander implants, in 500 patients, were performed. Several clinical variables were collected. In our study, we evaluated the different inflammatory markers present in the periprosthetic fluid and we compared them with the ones present in plasma. RESULTS: The surgical site infection rate resulted to be 10.5%, and reconstruction failed in 4.5% of the cases. The hazard ratio for complications was 2.3 in women over 60 (CI: 1.3-4.07; p = 0.004), 2.57 in patients with expander volume ≥ 500 cc (CI: 1.51-4.38; p < 0.001), 2.14 in patients submitted to previous radiotherapy (CI: 1.05-4.36; p < 0.037), and 1.05 in prolonged drain use (CI: 1.03-1.07; p < 0.001). 25-OH, PCT, and total protein were less concentrated, and ferritin and LDH were more concentrated in the periprosthetic fluid than in plasma (p < 0.001). CRP (p = 0.190) and ß-2 microglobulin (p = 0.344) did not change in the two fluids analyzed. PCT initial value is higher in patients who underwent radiotherapy, and it could be related to the higher rate of their postoperative complications. Patients with a tissue expander with a volume ≥ 500 cc show an increasing trend for CRP in time (p = 0.009). CONCLUSIONS: Several risk factors (prolonged time of drains, age older than 60 years, and radiotherapy) have been confirmed by our study. The study of markers in the periprosthetic fluid with respect to their study in plasma could point toward earlier infection detection and support early management.


Sujet(s)
Implants mammaires/effets indésirables , Mammoplastie/effets indésirables , Radiothérapie adjuvante , Infection de plaie opératoire , Adulte , Marqueurs biologiques/métabolisme , Femelle , Humains , Adulte d'âge moyen , Études prospectives , Études rétrospectives , Infection de plaie opératoire/métabolisme , Infection de plaie opératoire/anatomopathologie , Infection de plaie opératoire/radiothérapie
5.
Biomed Res Int ; 2020: 3261318, 2020.
Article de Anglais | MEDLINE | ID: mdl-33150171

RÉSUMÉ

INTRODUCTION: Acellular dermal matrix (ADM) products are adopted in the management of injuries to soft tissues. ADMs have been increasingly employed for their clinical advantages, and they are acquiring relevance in the future of plastic surgery. The aim of our study is to evaluate the application of ADMs in our patients who could not undergo fast reconstruction. MATERIALS AND METHODS: We performed a retrospective study on 12 patients who underwent ADM placement for scalp and limb surgical reconstructions at the Humanitas Research Hospital, Rozzano (Milano), Italy. Wounds resulted from 9 tumor resections and 3 chronic ulcers. The ADM substrate used to treat these lesions was PELNAC™ (Gunze, Japan), a double-layered matrix composed of atelocollagen porcine tendon and silicon reinforcement. All patients underwent a second surgical operation to complete the treatment with a full-thickness skin graft to cover the lesion. RESULTS: In this study, 12 patients were treated with PELNAC™: 11 out of 12 patients showed a good attachment over a median time of 21.3 days (range 14-27). After almost 23 days, all patients were ready to undergo a full-thickness skin grafting. CONCLUSION: This study assesses the benefits of PELNAC™ and proposes this method as an alternative to traditional approaches, especially in situations where the latter techniques cannot be applied.


Sujet(s)
Derme acellulaire , Tumeurs de la tête et du cou/chirurgie , /méthodes , Transplantation de peau/méthodes , Ulcère cutané/chirurgie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Animaux , Collagène/isolement et purification , Collagène/usage thérapeutique , Femelle , Tumeurs de la tête et du cou/anatomopathologie , Tumeurs de la tête et du cou/rééducation et réadaptation , Tumeurs de la tête et du cou/thérapie , Humains , Mâle , Adulte d'âge moyen , Études rétrospectives , Cuir chevelu/anatomopathologie , Cuir chevelu/chirurgie , Silicium/usage thérapeutique , Peau/anatomopathologie , Ulcère cutané/anatomopathologie , Ulcère cutané/rééducation et réadaptation , Ulcère cutané/thérapie , Peau artificielle , Suidae , Tendons/composition chimique , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Cicatrisation de plaie/physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE